BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao W, Cong Y, Li HM, Li S, Shen Y, Qi Q, Zhang Y, Li YZ, Tang YJ. Challenges and potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy. Nat Prod Rep 2021;38:470-88. [PMID: 32895676 DOI: 10.1039/d0np00041h] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Shi R, Fan H, Yu X, Tang Y, Jiang J, Liang X. Advances of podophyllotoxin and its derivatives: patterns and mechanisms. Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.115039] [Reference Citation Analysis]
2 Abtahi NA, Naghib SM, Haghiralsadat F, Reza JZ, Hakimian F, Yazdian F, Tofighi D. Smart stimuli-responsive biofunctionalized niosomal nanocarriers for programmed release of bioactive compounds into cancer cells in vitro and in vivo. Nanotechnology Reviews 2021;10:1895-911. [DOI: 10.1515/ntrev-2021-0119] [Reference Citation Analysis]
3 Wu ZX, Yang Y, Zeng L, Patel H, Bo L, Lin L, Chen ZS. Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell Line. Front Oncol 2020;10:624954. [PMID: 33692943 DOI: 10.3389/fonc.2020.624954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Huang M, Liu C, Shao Y, Zhou S, Hu G, Yin S, Pu W, Yu H. Anti-tumor pharmacology of natural products targeting mitosis. Cancer Biol Med 2022:j. [PMID: 35699421 DOI: 10.20892/j.issn.2095-3941.2022.0006] [Reference Citation Analysis]
5 Fedotcheva TA. Clinical Use of Progestins and Their Mechanisms of Action: Present and Future (Review). Sovrem Tekhnologii Med 2021;13:93-106. [PMID: 34513071 DOI: 10.17691/stm2021.13.1.11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tan FF, Zhu R, Xiong B, Zhang GM, Zhao W, Jia KZ. Engineering the Entrance of a Flavonoid Glycosyltransferase Promotes the Glycosylation of Etoposide Aglycone. ACS Synth Biol 2022;11:1874-80. [PMID: 35522995 DOI: 10.1021/acssynbio.2c00032] [Reference Citation Analysis]
7 Shah Z, Gohar UF, Jamshed I, Mushtaq A, Mukhtar H, Zia-Ui-Haq M, Toma SI, Manea R, Moga M, Popovici B. Podophyllotoxin: History, Recent Advances and Future Prospects. Biomolecules 2021;11:603. [PMID: 33921719 DOI: 10.3390/biom11040603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 An J, Liu Y, Duo S, Ma X, An L, Yan Y, Ji D, Yan Y, Cheng Q, Su Z. Podofilox suppresses gastric cancer cell proliferation by regulating cell cycle arrest and the c-Myc/ATG10 axis. Exp Ther Med 2021;22:1203. [PMID: 34584548 DOI: 10.3892/etm.2021.10637] [Reference Citation Analysis]
9 Serafino A, Chiminelli M, Balestri D, Marchiò L, Bigi F, Maggi RM, Malacria M, Maestri G. Dimerizing cascades of enallenamides reveal the visible-light-promoted activation of cumulated C-C double bonds. Chem Sci 2022;13:2632-9. [PMID: 35340858 DOI: 10.1039/d1sc06719b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kluska M, Woźniak K. Natural Polyphenols as Modulators of Etoposide Anti-Cancer Activity. Int J Mol Sci 2021;22:6602. [PMID: 34202987 DOI: 10.3390/ijms22126602] [Reference Citation Analysis]
11 Fan HY, Zhu ZL, Xian HC, Wang HF, Chen BJ, Tang YJ, Tang YL, Liang XH. Insight Into the Molecular Mechanism of Podophyllotoxin Derivatives as Anticancer Drugs. Front Cell Dev Biol 2021;9:709075. [PMID: 34447752 DOI: 10.3389/fcell.2021.709075] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
12 Zhang X, Yang T, Jin X, Lin K, Dai X, Gao T, Huang G, Fan M, Ma L, Liu Z, Cao J. Synthesis and biological evaluation of cytotoxic activity of novel podophyllotoxin derivatives incorporating piperazinyl-cinnamic amide moieties. Bioorganic Chemistry 2022;123:105761. [DOI: 10.1016/j.bioorg.2022.105761] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yang Z, Zhou Z, Luo X, Luo X, Luo H, Luo L, Yang W. Design and Synthesis of Novel Podophyllotoxins Hybrids and the Effects of Different Functional Groups on Cytotoxicity. Molecules 2021;27:220. [PMID: 35011453 DOI: 10.3390/molecules27010220] [Reference Citation Analysis]
14 Sun W, Sun F, Meng J, Cao X, Zhao S, Wang C, Li L, Jiang P. Design, semi-synthesis and bioactivity evaluation of novel podophyllotoxin derivatives as potent anti-tumor agents. Bioorganic Chemistry 2022;126:105906. [DOI: 10.1016/j.bioorg.2022.105906] [Reference Citation Analysis]
15 Liang B, Zhou D. ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication. Drug Deliv 2021;28:2361-72. [PMID: 34747277 DOI: 10.1080/10717544.2021.1995076] [Reference Citation Analysis]